Tekla Healthcare Investor...

NYSE: HQH · Real-Time Price · USD
16.43
0.17 (1.05%)
At close: Aug 15, 2025, 3:59 PM
16.40
-0.20%
After-hours: Aug 15, 2025, 05:53 PM EDT

Tekla Healthcare Investors Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
10.77M 9.97M 10.29M 9.94M 8.27M 7.17M 6.48M 7.18M
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
10.77M 9.97M 10.29M 9.94M 8.27M 7.17M 6.48M 7.18M
Operating Income
-220.27K -1.05M -1.19M -1.6M -3.67M -5.57M -6.23M -4.67M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
184.95M 72.87M 56.33M 3.98M -194.23M -48.44M 155.18M 281.74M
Net Income
184.95M 72.87M 56.33M 3.98M -194.23M -48.44M 155.18M 281.74M
Selling & General & Admin
10.99M 11.02M 11.48M 11.54M 11.94M 12.74M 12.71M 11.84M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
10.99M 11.02M 11.48M 11.54M 11.94M 12.74M 12.71M 11.84M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
56.39K 18.63K n/a n/a n/a n/a n/a n/a
Cost & Expenses
10.99M 11.02M 11.48M 11.54M 11.94M 12.74M 12.71M 11.84M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
53.63M 50.62M 50.53M 48.35M 48.34M 46.34M 46.2M 44.65M
Shares Outstanding (Diluted)
53.63M 50.62M 50.53M 48.35M 48.34M 46.34M 46.2M 44.65M
EPS (Basic)
3.56 1.44 1.19 0.08 -4.12 -1.04 3.42 6.31
EPS (Diluted)
3.56 1.44 1.19 0.08 -4.12 -1.04 3.42 6.31
EBITDA
n/a n/a n/a n/a n/a n/a n/a n/a
EBIT
-220.27K -1.05M -1.19M -1.6M -3.67M -5.57M -6.23M -4.67M
Depreciation & Amortization
220.27K 1.05M 1.19M 1.6M 3.67M 5.57M 6.23M 4.67M